The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland

The HIT network provides a unique structure for population-based state-of-the-art diagnostic assessments, treatment recommendations and counseling. It increases the "a priori" accuracy of stratification parameters, and the timely inclusion into clinical trials and tumor-specific registries. Favorable outcomes are achieved within the trials and registry landscape, for example, through consistent reference assessments, reducing the gap to real world data. Resulting data facilitate representative, unbiased high-quality research projects across all CNS tumor entities. Interdisciplinary cooperation and competitive scientific output are enhanced.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2026-03-16
DOI
https://doi.org/10.1002/1545-5017.70165
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland

Ahmed El Damaty, K. Scheinemann, Martin U. Schuhmann, Petra Ketteler et al.
Pediatric Blood & Cancer
Glioma Diagnosis and Treatment
article

The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland

Ahmed El Damaty, K. Scheinemann, Martin U. Schuhmann, Petra Ketteler, Martin Benesch, Christof M. Kramm, Andreas Faldum, Hermann L. Müller, Irene Slavc, Matthias Eyrich, Gudrun Fleischhack, Lisa Bußenius, Johannes Gojo, Pedram Emami, Monika Warmuth‐Metz, Astrid Gnekow, Till Milde, Barbara von Zezschwitz, Thomas Perwein, Karin Dieckmann, Uwe Kordes, O. Witt, Cécile M. Ronckers, Katja Baust, Holger Ottensmeier, Jürgen Debus, Martin Mynarek, Stephan Tippelt, D Sturm, Rolf D. Kortmann, Fabian Pöhl, Rudolf Schwarz, Carsten Friedrich, Beate Timmermann, Ulrich Schüller, Torsten Pietsch, Johannes E. A. Wolf, Pablo Hernáiz‐Driever, Ulrich‐Wilhelm Thomale, Arend Koch, Mechthild Krause, Nicolas U. Gerber, Pascal Johann, Martin Hasselblatt, Stefan M. Pfister, Gabriele Calaminus, David Capper, Stefan Schönberger, Christian Hagel, Christian Thomas, Desiree Grabow, David T. W. Jones, Stefan Rutkowski, André O. von Bueren, Michael C. Frühwald, Denise Obrecht‐Sturm, Brigitte Bison, Karoline Nemes, Jürgen Krauss, Felix Sahm
article en

Abstract

The HIT network provides a unique structure for population-based state-of-the-art diagnostic assessments, treatment recommendations and counseling. It increases the "a priori" accuracy of stratification parameters, and the timely inclusion into clinical trials and tumor-specific registries. Favorable outcomes are achieved within the trials and registry landscape, for example, through consistent reference assessments, reducing the gap to real world data. Resulting data facilitate representative, unbiased high-quality research projects across all CNS tumor entities. Interdisciplinary cooperation and competitive scientific output are enhanced.

Pediatric Blood & Cancer
University of Geneva (CH), University of Bonn (DE), Leipzig University of Applied Sciences (DE), Universität Hamburg (DE), University of Lucerne (CH), German Cancer Research Center (DE), Johannes Gutenberg University Mainz (DE), Medical University of Graz (AT), Heidelberg University (DE), University of Münster (DE), University of Würzburg (DE), University Hospital Bonn (DE), Helmholtz-Zentrum Dresden-Rossendorf (DE), University Hospital Augsburg (DE), University Hospital Heidelberg (DE), Humboldt-Universität zu Berlin (DE), Dr. August Wolff (Germany) (DE), Comprehensive Cancer Center Vienna (AT), University Medical Center of the Johannes Gutenberg University Mainz (DE), Comprehensive Cancer Center Mainfranken (DE), University Hospital Münster (DE), University Hospital of Geneva (CH), West Cancer Center (US), University Medical Center Hamburg-Eppendorf (DE), Kinderkrebs-Zentrum Hamburg (DE), Klinikum Oldenburg (DE), National Center for Tumor Diseases (DE), Hopp Children's Cancer Center Heidelberg (DE), Nephrologisches Zentrum Goettingen (DE), Essen University Hospital (DE), University Hospital Leipzig (DE), Universitätsklinikum Würzburg (DE), Heidelberg Engineering (Germany) (DE), University Children's Hospital Zurich (CH), Jena University Hospital (DE), STZ eyetrial (DE), University Hospital Carl Gustav Carus (DE), Ostschweizer Kinderspital (CH), University of Regensburg (DE), Medical University of Vienna (AT), University of Tübingen (DE), Heidelberg University (US), Leipzig University (DE)
Partnerships for the goals
Openalex Percentile: Top 20%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.